WJ Elliott, PM Meyer - The Lancet, 2007 - Elsevier Intitial drug therapy used in the trials (and the number of patients with
diabetes of the total number at risk) included: an ARB (1189 of 14 185, or
8·38%), ACE inhibitor (1618 of 22 941, or 7·05%), calcium-channel blocker ... Cited by 300 - Related articles - BL Direct - All 17 versions
- Free from Publisher G Roglic, N Unwin, PH Bennett, C Mathers, J … - Diabetes Care, 2005 - ncbi.nlm.nih.gov OBJECTIVE: To estimate the global number of excess deaths due to diabetes in the
year 2000. RESEARCH DESIGN AND METHODS: We used a computerized generic formal
disease model (DisMod II), used by the World Health Organization to assess ... Cited by 170 - Related articles - BL Direct - All 4 versions
- ►caldiabetes.org [PDF] - Free from Publisher DM Nathan, MB Davidson, RA DeFronzo, RJ … - Diabetes Care, 2007 - Am Diabetes Assoc Type 2 diabetes is now epidemic. In the US, there has been a 61% increase in
incidence between 1990 and 2001 (1). There are currently 1.5 million new cases
per year, and the prevalence in 2005 was almost 21 million (2). The ... Cited by 158 - Related articles - BL Direct - All 11 versions
PA Sarafidis, LM Ruilope - Am J Nephrol, 2006 - content.karger.com Most of the basic components of the metabolic syndrome, namely type 2 diabetes
mellitus, hypertension, obesity, or low high-density lipoprotein cholesterol
levels, apart from being major risk factors for cardiovascular disease have ... Cited by 67 - Related articles - BL Direct - All 5 versions
- ►dvdres.com [PDF] C Day - Diabetes & Vascular Disease Research, 2007 - dvr.sagepub.com Abstract T he 'metabolic syndrome' is a clustering of risk fac- tors which
predispose an individual to cardiovascu- lar morbidity and mortality. There is
general con- sensus regarding the main components of the syndrome (glucose ... Cited by 49 - Related articles - BL Direct - All 10 versions
SM Grundy - Endocrinology and metabolism clinics of North America, 2004 - Elsevier The metabolic syndrome is comprised of a clustering of metabolic risk factors in
one individual. The syndrome has been identified as a multidimensional risk
factor for cardiovascular disease (CVD). It also is associated with an ... Cited by 47 - Related articles - BL Direct - All 3 versions
- ►dvdres.com [PDF] T Saaristo, M Peltonen, J Lindstrom, L … - Diabetes and Vascular Disease Research, 2005 - dvdres.com Abstract The aim of this study was to assess the performance of the Finnish
Diabetes Risk Score as a screening tool for undetected type 2 diabetes (T2D),
abnormal glucose tolerance (AGT) and metabolic syndrome in the general ... Cited by 48 - Related articles - BL Direct - All 9 versions
JM Rijkelijkhuizen, G Nijpels, RJ Heine, LM … - Diabetes Care, 2007 - Am Diabetes Assoc OBJECTIVE—To optimize identification of future diabetic patients, the American
Diabetes Association (ADA) introduced criteria for impaired fasting glucose
(IFG) in 1997 (IFG 6.1 mmol/l [IFG6.1]) and lowered the threshold from 6.1 ... Cited by 31 - Related articles - BL Direct - All 5 versions
MS Rendell, L Jovanovic - Metabolism, 2006 - Elsevier In healthy individuals, blood glucose levels in the fasting state are maintained
by the continuous basal-level insulin secretion. After a meal, the rise in
postprandial glucose (PPG) is controlled by the rapid pancreatic release of ... Cited by 30 - Related articles - All 12 versions
- ►diabetesjournals.org G Roglic, N Unwin, PH Bennett, C Mathers, J … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We used a computerized generic formal disease
model (DisMod II), used by the World Health Organization to assess disease
burden through modeling the relationships between incidence, prevalence, ... Cited by 25 - Related articles - All 13 versions
